Novaquin (Meloxicam)

Meloxicam works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which is responsible for producing prostaglandins that promote inflammation, pain, and fever. By reducing prostaglandin synthesis at sites of tissue injury, meloxicam dampens the inflammatory response and provides analgesic effects while sparing some gastric protective prostaglandins.

The specific dose of Novaquin is determined by the prescribing clinician based on the individual’s medical condition, severity, and response to therapy. Healthcare professionals consider factors such as age, renal function, and concomitant medications before selecting an appropriate dosage regimen.

Meloxicam, like other NSAIDs, is generally avoided during the third trimester of pregnancy because it may affect fetal cardiovascular function. Limited data exist for use in early pregnancy and during lactation, so clinicians weigh potential benefits against risks and may recommend alternative therapies when safety cannot be assured.

To request Novaquin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Novaquin (meloxicam) offers a longer half‑life and greater COX‑2 selectivity compared with non‑selective NSAIDs like ibuprofen. This can allow once‑daily dosing and may reduce gastrointestinal irritation, though individual response varies. Choice of NSAID depends on patient‑specific factors, including cardiovascular risk, GI history, and renal function.

Novaquin should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging to protect them from moisture and light. Do not store in areas with high humidity or extreme heat, and keep out of reach of children.

Novaquin is supplied as oral tablets that are taken by mouth with a full glass of water. It may be taken with or without food, although taking it with food can reduce occasional stomach upset. Patients should follow the dosing schedule prescribed by their healthcare provider.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as myocardial infarction or stroke, severe skin reactions like Stevens‑Johnson syndrome, and renal impairment. Patients should be monitored for signs of these conditions, and therapy should be discontinued promptly if serious adverse events occur.

Novaquin should be avoided in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal ulceration or bleeding, patients with severe renal or hepatic impairment, and during the third trimester of pregnancy. Clinicians must also assess cardiovascular risk before initiating therapy.